Please assess the completion status of the following clinical trial:

Trial Title: Management of Uncontrolled Hypertension (HTN)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria~1. Age ≥ 18 years~2. Blood pressure of \>130/80 mmHg~3. Currently receiving 3 anti-hypertensive agents, one of which is a diuretic, for at least six weeks~Exclusion criteria~1. Vulnerable populations~1. Pregnant women~2. Prisoners~3. Cognitively impaired persons~4. Economically and/or educationally disadvantaged~5. Human fetuses and neonates~6. Patients who work night-shift~7. Children~8. Conditions with visual field deterioration (Anterior Ischemic Optic Neuropathy, Glaucoma, Optic Nerve Disorders)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Chronotherapy (Type: ACTIVE_COMPARATOR): Chronotherapy group automatically receives a shift in 1 anti-hypertensive medication to night-time without assessment of ambulatory blood pressure monitor results.
- ABPM (Type: ACTIVE_COMPARATOR): ABPM group will have their ambulatory blood pressure monitor results reviewed prior to deciding to change regimen.

Based on this trial design, predict the completion outcome and termination type (if applicable).